Could a quick digital test and blood draw detect Alzheimer's years early?

NCT ID NCT07284264

Recruiting now Diagnosis Sponsor: Xuanwu Hospital, Beijing Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This nationwide study in China aims to improve early detection of Alzheimer's disease. Researchers will screen 6,000 adults aged 50 and older using a digital cognitive test and a questionnaire, followed by blood tests to confirm Alzheimer's-related changes. The goal is to see if this stepwise approach is accurate and practical for community use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, widely available screening program for early Alzheimer's detection using digital tools and blood tests.
What could go wrong: This is an observational study, not a treatment trial. The screening methods may not be accurate enough for real-world use, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEMENTIA

Contacts and locations

Locations

General Hospital of Ningxia Medical University
RECRUITING

Ningxiang, China
Hainan Medical University
RECRUITING

Hainan, China
Shenzhen Center For Chronic Disease Control
RECRUITING

Shenzhen, China
The First Hospital of China Medical Unversity
RECRUITING

Shenyang, China
Xuanwu Hospital, Capital Medical University
RECRUITING

Beijing, China
Yichun People'S Hospital
RECRUITING

Yichun, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.